| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $677.6M | +60.1% |
| Cost of Revenue | $77.7M | +27.5% |
| R&D Expense | $96.9M | -13.2% |
| SG&A Expense | $196.3M | +16.8% |
| Operating Income | $77.2M | +269.3% |
| Pre-tax Income | $88.9M | +345.8% |
| Income Tax | $29.9M | +324.1% |
| Net Income | $59.0M | +236.6% |
| EPS (Basic) | $0.80 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $165.6M | -9.8% |
| Short-term Investments | $248.5M | +313.8% |
| Accounts Receivable | $15.6M | -62.6% |
| Inventory | $54.9M | +108.2% |
| Current Assets | $527.2M | +58.9% |
| Total Assets | $763.6M | +31.5% |
| Current Liabilities | $139.2M | +38.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $138.0M | +437.1% |
| Capital Expenditures | $1.6M | +466.1% |
| Investing Cash Flow | -$189.0M | -601.7% |
| Financing Cash Flow | $33.0M | +169.2% |
| Free Cash Flow | $136.4M | +436.8% |
| +233.3% |
| EPS (Diluted) | $0.75 | +225.0% |
| Total Liabilities |
| $196.0M |
| +37.9% |
| Stockholders' Equity | $567.6M | +29.5% |